NON-SCARRING ALOPECIA

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting NON-SCARRING ALOPECIA:

# Drug Count
0 ADALIMUMAB 4
1 ADALIMUMAB-AATY 4
2 ADALIMUMAB-ADAZ 4
3 ADALIMUMAB-FKJP 4
4 OLMESARTAN MEDOXOMIL 3
5 PREDNISONE 3
6 DUPILUMAB 2
7 EFAVIRENZ 2
8 LAMIVUDINE 2
9 LAMIVUDINE ORAL 2
See all common drugs associated with NON-SCARRING ALOPECIA

NON-SCARRING ALOPECIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RITLECITINIB 1 0.0005
1 TENOFOVIR DISOPROXIL FUMARATE TABLETS 2 0.0002
2 RIPRETINIB 1 0.0002
3 EFAVIRENZ 2 0.0002
4 BENZOYL PEROXIDE 1 0.0001
5 PEGVALIASE-PQPZ 1 0.0001
6 DASATINIB 1 0.0001
7 ADALIMUMAB-FKJP 4 0.0001
8 OLMESARTAN MEDOXOMIL 3 0.0001
9 ADALIMUMAB-AATY 4 0.0001
See all drugs enriched for association with NON-SCARRING ALOPECIA